GGrantIndex
Sort

59,101 grants matching hypertension

Mechanisms of Right Ventricular Dysfunction in Scleroderma-associated PAH

$678,878
Paul M Hassoun · Johns Hopkins University · R01 · FY2020 · HL

Mediators of Atherosclerosis in South Asians Living in America

$678,794
Alka M Kanaya · University Of California, San Francisco · R01 · FY2016 · HL

EPIDEMIOLOGY: OXIDATIVE STRESS AND EARLY ATHEROSCLEROSIS

$678,762
University Of Minnesota Twin Cities · R01 · FY2001 · HL

Emergence of Cardiometabolic Risk Across the Lifecycle in China

$678,745
Penny Gordon-Larsen · Univ Of North Carolina Chapel Hill · R01 · FY2014 · HL

Insulin-Like Growth Factor-1 and Atherosclerosis

$678,728
Patrice Delafontaine Delafontaine · Tulane University Of Louisiana · R01 · FY2025 · HL

Training Program in Hypertension

$678,703
Gail Kurr Adler · Brigham And Women'S Hospital · T32 · FY2021 · HL

Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females

$678,675
Tony Yuen · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG

Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy

$678,661
Joseph C Wu · Stanford University · R01 · FY2025 · HL

Blood Pressure, Cerebral Perfusion & Cognitive Outcome In Hypertension.

$678,659
Lidia Glodzik · New York University School Of Medicine · R01 · FY2014 · HL

Effectiveness of an evidence-based health coaching program for reducing cardiometabolic risk among women and infants enrolled in early home visiting services

$678,650
Kelly Bower · Johns Hopkins University · P50 · FY2024 · MD

Circadian origins of vascular disease in obesity

$678,625
David W Stepp · Augusta University · R01 · FY2019 · HL

The Role of Neighborhood Deprivation on Diabetes Outcomes: A Mixed Methods Study

$678,598
Joni Strom Williams · Medical College Of Wisconsin · R01 · FY2025 · DK

Significance of Epac signaling in renal Na+handling and hypertension

$678,566
Oleh Pochynyuk · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DK

Significance of Epac signaling in renal Na+handling and hypertension

$678,566
Oleh Pochynyuk · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DK

Age Associated Changes In Structural And Functional Cardio-Vascular Properties

$678,284
Edward Lakatta · National Institute On Aging · ZIA · FY2019 · AG

Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care setting

$678,273
Jennifer C. Lai · University Of California, San Francisco · R01 · FY2024 · DK

Interactive Tele-Pharmacy to Improve Chronic Medication Adherence

$678,265
Niteesh K Choudhry · Brigham And Women'S Hospital · R01 · FY2015 · HL

Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

$678,150
Jonathan Lee Slaughter · Research Inst Nationwide Children'S Hosp · R01 · FY2020 · HL

Clinical Applications of Nitrite and Nitrate

$678,132
Alan Schechter · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Cardiovascular Health Trajectories from Birth Thru Adolescence in A Diverse Cohort of Children

$678,094
Norrina Bai Allen · Northwestern University At Chicago · R01 · FY2023 · HL

Role of Genetic Susceptibility in the Central American Kidney Disease Epidemic

$678,087
Daniel R Brooks · Boston University Medical Campus · R01 · FY2021 · DK

Genetic Studies of The Impact of Hematologic Traits On Cardiovascular Disease

$678,076
Santhi K Ganesh · University Of Michigan At Ann Arbor · R01 · FY2019 · HL

Racial/Ethnic Influences on Early Vascular Aging and Cardiac Strain: Role of Cumulative Stress, Inflammatory and Metabolic Burden

$678,060
Uma Rao · University Of California-Irvine · R01 · FY2025 · HL

An Unobtrusive Continuous Cuff-less Blood Pressure Monitor for Nocturnal Hypertension

$678,001
Roozbeh Jafari · Texas Engineering Experiment Station · R01 · FY2021 · HL

Metabolic and Vascular Factors in tau pathogenesis

$677,968
Sally Ann Frautschy · University Of California Los Angeles · R01 · FY2021 · AG